Ontrak, Inc. Expected to Post FY2028 Earnings of $0.12 Per Share (NASDAQ:OTRK)

Posted by Doug Wharley on Apr 19th, 2024

Ontrak, Inc. (NASDAQ:OTRK – Free Report) – Research analysts at Roth Capital issued their FY2028 earnings per share estimates for shares of Ontrak in a research report issued on Tuesday, April 16th. Roth Capital analyst J. Aschoff anticipates that the company will post earnings per share of $0.12 for the year. The consensus estimate for Ontrak’s current full-year earnings is ($0.34) per share.

Ontrak Trading Up 1.5 %

NASDAQ OTRK opened at $0.28 on Friday. Ontrak has a 52 week low of $0.14 and a 52 week high of $4.08. The business’s fifty day simple moving average is $0.28 and its 200-day simple moving average is $0.46.

Institutional Trading of Ontrak

Several institutional investors and hedge funds have recently bought and sold shares of OTRK. Two Sigma Investments LP raised its holdings in Ontrak by 119.9% in the 1st quarter. Two Sigma Investments LP now owns 51,600 shares of the company’s stock valued at $27,000 after buying an additional 28,131 shares during the period. B. Riley Wealth Advisors Inc. purchased a new stake in Ontrak in the 3rd quarter valued at about $34,000. Renaissance Technologies LLC purchased a new stake in Ontrak during the second quarter worth about $35,000. Charles Schwab Investment Management Inc. increased its stake in Ontrak by 51.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 29,007 shares of the company’s stock worth $66,000 after purchasing an additional 9,895 shares during the period. Finally, XTX Topco Ltd increased its stake in Ontrak by 273.2% during the first quarter. XTX Topco Ltd now owns 50,431 shares of the company’s stock worth $114,000 after purchasing an additional 36,918 shares during the period. 12.95% of the stock is currently owned by hedge funds and other institutional investors.

Ontrak Company Profile

(Get Free Report)

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.